COVAXIN: Human trials of India’s first coronavirus vaccine on 1,100 people to begin soon

India's first coronavirus vaccine COVAXIN, by Hyderabad-based Bharat Biotech, is expected to begin human trials of its candidate by next week. COVAXIN, which is India’s first indigenous vaccine against the novel coronavirus (COVID-19) and has been developed by Bharat Biotech in collaboration with ICMR and NIV, Pune. COVAXIN will be tested on more than 1,100 people in phase 1 and 2 clinical trials, in which more than 1,100 people are expected to be enrolled 

from IndiaTV India: Google News Feed https://ift.tt/2O2C5PT

Get Breaking news, Live news, and latest news from India and around the world on INDILIVENEWS.com, which are in the interest of nation and humanity. Like us on Facebook or Follow us on Twitter and Reddit for the latest news blog and live news update

Trending News